SIMPLICITY Trademark

Trademark Overview

On Tuesday, March 8, 2011, a trademark application was filed for SIMPLICITY with the United States Patent and Trademark Office. The USPTO has given the SIMPLICITY trademark a serial number of 85260866. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 2, 2025. This trademark is owned by Bristol-Myers Squibb Company. The SIMPLICITY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

General Information

Serial Number85260866
Word MarkSIMPLICITY
Filing DateTuesday, March 8, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 2, 2025
Registration Number4625198
Registration DateTuesday, October 21, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 7, 2011

Trademark Statements

Description of MarkThe mark consists of the word "SIMPLICITY" in stylized lettering and a circle next to the word and a line underneath.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 2, 2025
Primary Code042
First Use Anywhere DateFriday, October 1, 2010
First Use In Commerce DateFriday, October 1, 2010

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Friday, March 11, 2011NEW APPLICATION ENTERED
Friday, March 11, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 12, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Monday, April 18, 2011ASSIGNED TO EXAMINER
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 5, 2011ASSIGNED TO LIE
Tuesday, June 7, 2011PUBLISHED FOR OPPOSITION
Thursday, May 5, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 18, 2011NOTICE OF PUBLICATION
Tuesday, August 2, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2012SOU TEAS EXTENSION RECEIVED
Tuesday, January 17, 2012SOU EXTENSION 1 FILED
Monday, February 13, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 13, 2012SOU EXTENSION 1 GRANTED
Tuesday, February 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, July 18, 2012SOU TEAS EXTENSION RECEIVED
Wednesday, July 18, 2012SOU EXTENSION 2 FILED
Thursday, July 19, 2012SOU EXTENSION 2 GRANTED
Friday, July 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, January 15, 2013SOU TEAS EXTENSION RECEIVED
Tuesday, January 15, 2013SOU EXTENSION 3 FILED
Wednesday, January 16, 2013SOU EXTENSION 3 GRANTED
Thursday, January 17, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, April 3, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 2, 2013SOU TEAS EXTENSION RECEIVED
Friday, August 2, 2013SOU EXTENSION 4 FILED
Wednesday, August 7, 2013SOU EXTENSION 4 GRANTED
Thursday, August 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 3, 2014SOU EXTENSION 5 FILED
Tuesday, February 18, 2014TEAS PETITION TO REVIVE RECEIVED
Tuesday, February 18, 2014PETITION TO REVIVE-GRANTED
Tuesday, February 18, 2014SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, February 18, 2014NOTICE OF REVIVAL - E-MAILED
Tuesday, March 25, 2014SOU EXTENSION 5 GRANTED
Wednesday, March 26, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 27, 2014TEAS STATEMENT OF USE RECEIVED
Sunday, July 27, 2014USE AMENDMENT FILED
Sunday, August 3, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, September 15, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 16, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 21, 2014REGISTERED-PRINCIPAL REGISTER
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 21, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 14, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 28, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 28, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 28, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 28, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 28, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 19, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 19, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 19, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 21, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, May 2, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

simplicity relating pharmaceutical preparations human trials clinical scientific research namely conducting